)
Drug firm Ajanta Pharma today reported a 40.88 per cent increase in its standalone net profit to Rs 78.63 crore for the quarter ended September 30, 2014, mainly on account of robust exports.
The company had posted a net profit of Rs 55.81 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a filing to BSE.
Standalone total income of the company also rose to Rs 337.30 crore for the quarter under consideration from Rs 279.83 crore for the same period year ago.
"Our business performance remained aligned to all our plans in all the markets we operate in...," Ajanta Pharma Managing Director Yogesh M Agrawal said.
Exports contributed 64 per cent of the revenue for the quarter, the company said.
Shares of Ajanta Pharma were today trading at Rs 1,888.80 per scrip in the afternoon trade on BSE, up 4.16 per cent from its previous close.
